Cite
HARVARD Citation
Katz, L. et al. (2016). AMG 151 (ARRY‐403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (2), pp. 191-195. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Katz, L. et al. (2016). AMG 151 (ARRY‐403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes. Diabetes, obesity & metabolism. 18 (2), pp. 191-195. [Online].